Multiple Sclerosis – Cladribine tablets (Mavenclad)

23rd January 2018 by Louise Hudman

Multiple Sclerosis – Cladribine tablets (Mavenclad)

This is a new guideline from NICE on a new treatment for MS. Obviously we won’t be prescribing this, but I thought it worth mentioning as we may see patients starting to use it.

It is an oral medication, given as short courses (eg for 2 years, it is given for just a few days in each of a couple of months). This compares to other medications, which are either daily and continuous, or injections, or IV medications given in hospital.

It will be used as a second line treatment in relapsing-remitting MS, or in rapidly evolving severe relapsing-remitting MS.

Read for free

Sign up to access everything.

Free trial

Login

Already a member? Login to view this content.

Login

"I have found LocumDeck to be the most helpful and invaluable resource for keeping bookings and accounts. I want to thank you for the wonderful service you provide. Many thanks once again for all the NASGP provides, and particularly for use of the excellent resource LocumDeck has proved to be – something I have recommended to many colleagues who have taken a step to locum work."

Dr Ruth Snowball

Dr Ruth Snowball

See the full list of features within our NASGP membership plans

Membership